HHS Secretary Kathleen Sebelius announced today that the department will take important steps necessary to prepare for potential commercial-scale production of a candidate vaccine for the novel Influenza A ( H1N1). The Secretary is directing approximately $1 billion in existing funds that will be used for clinical studies that will take place over the summer and for commercial-scale production of two potential vaccine ingredients for the pre-pandemic influenza stockpile.
HHS Takes Additional Steps Toward Development of Vaccine for the Novel Influenza A (H1N1)
Sunday, May 24, 2009
HHS Takes Additional Steps Toward Development of Vaccine for the Novel Influenza A (H1N1)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment